Therapeutic Strategies to Overcome Payload Resistance of Trastuzumab Deruxtecan in HER2-Positive Cancers.

Cancer Sci · 2026 · PMC13045244 · PMID 41548044

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although N87 cells exhibited a marginally higher uptake, the difference did not reach statistical significance ( n = 10 cells/group, unpaired two‐tailed t ‐test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.